JESSICA WARD: Open Payments
NPI 1861112260 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 31 payments from 18 companies in 2025. Trend: 2023 $18 · 2024 $89 · 2025 $679
Food & beverage: $679
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $124 |
| UCB, Inc. | 5 | $113 |
| ABBVIE INC. | 3 | $57 |
| CSL Behring | 2 | $42 |
| Mallinckrodt Hospital Products Inc. | 2 | $40 |
| JAZZ PHARMACEUTICALS INC. | 1 | $32 |
| Lilly USA, LLC | 2 | $29 |
| EMD Serono, Inc. | 1 | $29 |
| SK Life Science, Inc. | 1 | $29 |
| ARGENX US, INC. | 1 | $29 |
Products named: PONVORY, Rystiggo, QULIPTA, Hizentra, ACTHAR, Fintepla, EPIDIOLEX, KISUNLA.
Industry payments across AZ — which companies pay providers there.
